Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART)

Journal of Molecular Diagnostics

Volumn 15, Issue 3, 2013, Pages 401-412

  Morabito, Kenneth ^a,b   Kantor, Rami ^c   Tai, Warren ^a,b   Schreier, Leeann ^c   Tripathi, Anubhav ^a,b  

^a Brown University   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DEVICES; DIAGNOSTIC ACCURACY; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; QUANTITATIVE ASSAY; REPRODUCIBILITY; RNA ISOLATION; RNA PROBE; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SIMPLE METHOD TO AMPLIFY RNA TARGETS; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; WILD TYPE;

DRUG RESISTANCE, VIRAL; ENDPOINT DETERMINATION; GENOTYPE; HIV REVERSE TRANSCRIPTASE; HIV-1; MUTATION; NUCLEIC ACID HYBRIDIZATION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SELF-SUSTAINED SEQUENCE REPLICATION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, RNA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84876502403     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.02.005     Document Type: Article

References (40)

1. J.A. Levy, B. Autran, R.A. Coutinho, and J.P. Phair 25 Years of AIDS: recording progress and future challenges AIDS 26 2012 1187 1189
2. F. Clavel, and A.J. Hance HIV drug resistance N Engl J Med 350 2004 1023 1035
3. V.A. Johnson, V. Calvez, H.F. Günthard, R. Paredes, D. Pillay, R. Shafer, A.M. Wensing, and D.D. Richman 2011 Update of the drug resistance mutations in HIV-1 Top Antivir Med 19 2011 156 164
4. C.F. Gilks, S. Crowley, R. Ekpini, S. Gove, J. Perriens, Y. Souteyrand, D. Sutherland, M. Vitoria, T. Guerma, and K. De Cock The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings Lancet 368 2006 505 510
5. S. Gianella, W. Delport, M.E. Pacold, J.A. Young, J.Y. Choi, S.J. Little, D.D. Richman, S.L.K. Pond, and D.M. Smith Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants J Virol 85 2011 8359 8367
6. S. Gianella, and D.D. Richman Minority variants of drug-resistant HIV J Infect Dis 202 2010 657 666
7. S.A. Fiscus, B. Cheng, S.M. Crowe, L. Demeter, C. Jennings, V. Miller, R. Respess, W. Stevens Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group HIV-1 viral load assays for resource-limited settings PLoS Med 3 2006 e417
8. C.D. Chin, T. Laksanasopin, Y.K. Cheung, D. Steinmiller, V. Linder, H. Parsa, J. Wang, H. Moore, R. Rouse, G. Umviligihozo, E. Karita, L. Mwambarangwe, S.L. Braunstein, J. van de Wijgert, R. Sahabo, J.E. Justman, W. El-Sadr, and S.K. Sia Microfluidics-based diagnostics of infectious diseases in the developing world Nat Med 17 2011 1015 1019
9. R.J. O'Connell, T.M. Merritt, J.A. Malia, T.C. VanCott, M.J. Dolan, H. Zahwa, W.P. Bradley, B.M. Branson, N.L. Michael, and C.C. De Witt Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy J Clin Microbiol 41 2003 2153 2155
10. S. Wang, F. Xu, and U. Demirci Advances in developing HIV-1 viral load assays for resource-limited settings Biotechnol Adv 28 2010 770 781
11. C. Cabrera, S. Marfil, E. Poveda, T. Puig, A. Bonjoch, R. Ziermann, V. Soriano, B. Clotet, and L. Ruiz Comparative evaluation of the TRUGENE HIV-1 envelope (gp41) genotyping assay on clinical samples Antiviral Ther 10 2005 S48
12. J.D. Church, D. Jones, T. Flys, D. Hoover, N. Marlowe, S. Chen, C.J. Shi, J.R. Eshleman, L.A. Guay, J.B. Jackson, N. Kumwenda, T.E. Taha, and S.H. Eshleman Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D J Mol Diagn 8 2006 430 432
13. R.M. Grant, D.R. Kuritzkes, V.A. Johnson, J.W. Mellors, J.L. Sullivan, R. Swanstrom, R.T. D'Aquila, M. Van Gorder, M. Holodniy, R.M. Lloyd, C. Reid, G.F. Morgan, and D.L. Winslow Accuracy of the TRUGENE HIV-1 genotyping kit J Clin Microbiol 41 2003 1586 1593
14. E.C. Bile, C. Adje-Toure, M.Y. Borget, M. Kalou, F. Diomande, T. Chorba, and J.N. Nkengasong Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02-AG strains of HIV-1 in Abidjan, Cote d'Ivoire J Clin Virol 32 2005 60 66
15. E.K. Halvas, G.M. Aldrovandi, P. Balfe, I.A. Beck, V.F. Boltz, J.M. Coffin, L.M. Frenkel, J.D. Hazelwood, V.A. Johnson, M. Kearney, A. Kovacs, D.R. Kuritzkes, K.J. Metzner, D.V. Nissley, M. Nowicki, S. Palmer, R. Ziermann, R.Y. Zhao, C.L. Jennings, J. Bremer, D. Brambilla, and J.W. Mellors Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency J Clin Microbiol 44 2006 2612 2614
16. J.Z. Li, R. Paredes, H.J. Ribaudo, E.S. Svarovskaia, K.J. Metzner, M.J. Kozal, K.H. Hullsiek, M. Balduin, M.R. Jakobsen, A.M. Geretti, R. Thiebaut, L. Ostergaard, B. Masquelier, J.A. Johnson, M.D. Miller, and D.R. Kuritzkes Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis JAMA 305 2011 1327 1335
17. J.Z. Li, R. Paredes, H. Ribaudo, E.S. Svarooskaia, M.J. Kozal, K.H. Hullsiek, M.D. Miller, D. Bangsberg, and D.R. Kuritzkes Relationship between NNRTI adherence and low-frequency resistance mutations with the risk of virological failure Antiviral Ther 16 2011 A16
18. C.L. Wang, Y. Mitsuya, B. Gharizadeh, M. Ronaghi, and R.W. Shafer Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance Genome Res 17 2007 1195 1201
19. G.M. Ellis, M. Mahalanabis, I.A. Beck, G. Pepper, A. Wright, S. Hamilton, S. Holte, W.E. Naugler, D.M. Pawluk, C.C. Li, and L.M. Frenkel Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma J Clin Microbiol 42 2004 3670 3674
20. H.B. Gale, V.L. Kan, and R.C. Shinol Performance of the TruGene human immunodeficiency virus type 1 genotyping kit and OpenGene DNA sequencing system on clinical samples diluted to approximately 100 copies per milliliter Clin Vaccine Immunol 13 2006 235 238
21. A. Kapoor, M. Jones, R.W. Shafer, S.Y. Rhee, P. Kazanjian, and E.L. Delwart Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay J Virol 78 2004 7112 7123
22. S. Palmer, M. Kearney, F. Maldarelli, E.K. Halvas, C.J. Bixby, H. Bazmi, D. Rock, J. Falloon, R.T. Davey, R.L. Dewar, J.A. Metcalf, S. Hammer, J.W. Mellors, and J.M. Coffin Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis J Clin Microbiol 43 2005 406 413
23. C. Shi, S.H. Eshleman, D. Jones, N. Fukushima, L. Hua, A.R. Parker, C.J. Yeo, R.H. Hruban, M.G. Goggins, and J.R. Eshleman LigAmp: sensitive detection of single nucleotide differences Nat Methods 1 2004 141 147
24. B. Wang, D.E. Dwyer, C.B. Chew, C. Kol, Z.P. He, H. Joshi, M.C. Steain, A.L. Cunningham, and N.K. Saksena Sensitive detection of the K103N non-nucleoside reverse transcriptase inhibitor resistance mutation in treatment-naive HIV-1 infected individuals by rolling circle amplification J Virol Methods 161 2009 128 135
25. N. Kobayashi, K. Tamura, and T. Aotsuka PCR error and molecular population genetics Biochem Genet 37 1999 317 321
26. J.R. Dyer, B.L. Gilliam, J.J. Eron, L. Grosso, M.S. Cohen, and S.A. Fiscus Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA(TM) with Amplicor(TM) reverse transcription-PCR amplification and correlation with quantitative culture J Virol Methods 60 1996 161 170
27. A.M. Vandamme, S. Van Dooren, W. Kok, P. Goubau, K. Fransen, T. Kievits, J.C. Schmit, E. De Clercq, and J. Desmyter Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR J Virol Methods 52 1995 121 132
28. S.E. McCalla, and A. Tripathi Microfluidic reactors for diagnostics applications Ann Rev Biomed Eng 13 2011 321 343
29. K.J. Luebke, R.P. Balog, and H.R. Garner Prioritized selection of oligodeoxyribonucleotide probes for efficient hybridization to RNA transcripts Nucleic Acids Res 31 2003 750 758
30. J.C. Guatelli, K.M. Whitfield, D.Y. Kwoh, K.J. Barringer, D.D. Richman, and T.R. Gingeras Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication Proc Natl Acad Sci U S A 87 1990 1874 1878
31. B. Deiman, P. van Aarle, and P. Sillekens Characteristics and applications of nucleic acid sequence-based amplification (NASBA) Mol Biotechnol 20 2002 163 179
32. J. Compton Nucleic-acid sequence-based amplification Nature 350 1991 91 92
33. P. Gupta, J. Mellors, L. Kingsley, S. Riddler, M.K. Singh, S. Schreiber, M. Cronin, and C.R. Rinaldo High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors J Virol 71 1997 6271 6275
34. B. van Gemen, R. van Beuningen, A. Nabbe, D. van Strijp, S. Jurriaans, P. Lens, and T. Kievits A one-tube quantitative HIV-1 RNA NASBA nucleic-acid amplification assay using electrochemiluminescent (ECL) labelled probes J Virol Methods 49 1994 157 167
35. A.M. Vandamme, J.C. Schmit, S. Van Dooren, K. Van Laethem, E. Gobbers, W. Kok, P. Goubau, M. Witvrouw, W. Peetermans, E. DeClercq, and J. Desmyter Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test J Acquir Immune Defic Syndr Hum Retrovirol 13 1996 127 139
36. M. Segondy, T.D. Ly, M. Lapeyre, and B. Montes Evaluation of the nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma J Clin Microbiol 36 1998 3372 3374
37. J. Yao, Z. Liu, L.S. Ko, G. Pan, and Y. Jiang Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay J Virol Methods 129 2005 40 46
38. S.E. McCalla, C. Ong, A. Sarma, S.M. Opal, A.W. Artenstein, and A. Tripathi A simple method for amplifying RNA targets (SMART) J Mol Diagn 14 2012 328 335
39. R. Kantor Impact of HIV-1 pol diversity on drug resistance and its clinical implications Curr Opin Infect Dis 19 2006 594 606
40. R. Kantor, D.A. Katzenstein, B. Efron, A.P. Carvalho, B. Wynhoven, P. Cane, J. Clarke, S. Sirivichayakul, M.A. Soares, J. Snoeck, C. Pillay, H. Rudich, R. Rodrigues, A. Holguin, K. Ariyoshi, M.B. Bouzas, P. Cahn, W. Sugiura, V. Soriano, L.F. Brigido, Z. Grossman, L. Morris, A.M. Vandamme, A. Tanuri, P. Phanuphak, J.N. Weber, D. Pillay, P.R. Harrigan, R. Camacho, J.M. Schapiro, and R.W. Shafer Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration PLoS Med 2 2005 e112